Condition Guide Updated March 2026 11 min read

Red Light Therapy for Knee Pain: What 5 Studies Show

Knee pain affects more than 25% of adults, but emerging research shows that photobiomodulation (light-based therapy) can reduce pain and inflammation at the cellular level without systemic medication.

20+ years of research ✓ FDA 510(k) Cleared 4.8/5 rating 30-days free trial

Knee osteoarthritis affects over 10 million Americans, and the number is growing as our population ages. For many patients, cartilage degeneration doesn't heal on its own—the joint's poor blood supply limits nutrient delivery and repair. Traditional treatment focuses on pain management through NSAIDs or steroid injections, but these address symptoms rather than underlying inflammation and cellular dysfunction.

Red light therapy, or Low-Level Laser Therapy (LLLT), takes a different approach. Instead of masking pain, it works at the mitochondrial level—energizing cells to reduce inflammatory markers, accelerate ATP production, and promote cartilage healing. Over the past two decades, rigorous clinical trials have demonstrated that LLLT with specific wavelengths and energy doses can significantly reduce knee pain and improve function in both osteoarthritis and post-injury recovery.

This guide reviews the five most impactful studies, explains the mechanism of action, and shows you exactly how to apply red light therapy to your knee for maximum clinical effect.

Does Red Light Therapy Help Knee Pain?

The short answer is yes—and the evidence is robust. Research shows that red light therapy reduces knee osteoarthritis pain, decreases inflammation, and improves function when applied with correct dosing parameters. The key is matching the wavelength and energy density to what the clinical evidence supports. The most consistent results come from 660 nm and 808 nm wavelengths applied at 4–8 joules per centimeter squared, delivered over 10–16 sessions.

What the Research Shows

Below are the five landmark studies that establish red light therapy as an evidence-based treatment for knee pain. Each citation is linked directly to PubMed so you can review the full methodology and results.

Knee Osteoarthritis—The Strongest Evidence

The most comprehensive analysis comes from a 2019 meta-analysis published in BMJ Open, which pooled data from 1,063 patients across multiple randomized controlled trials. Research shows that LLLT reduces pain and disability at 4–8 J with 785–860 nm wavelengths—a finding that directly validates the wavelength and dosing strategy of the MOVE+. The effect size was clinically significant, with patients reporting an average pain reduction of 30–50% over 8–12 weeks.

A complementary 2023 meta-analysis of 820 patients reinforced these results, confirming that LLLT reduces pain at 4–8 J with 640–905 nm wavelength when applied for 10–16 sessions. Treatment protocols averaging 5 sessions per week for 8–12 weeks produced the most durable results.

Post-Injury Knee Pain and Inflammation

Beyond osteoarthritis, red light therapy addresses acute inflammation and pain after knee injury. A 2024 meta-analysis in the Journal of Physical Therapy analyzed 542 patients with various knee conditions and found that photobiomodulation reduces pain intensity in knee conditions and may improve disability outcomes.

Similarly, another 2024 analysis of 673 patients demonstrated that LLLT with 904–905 nm or 785–808 nm wavelengths yields significantly better pain reduction, establishing a clear dosing window for clinical practice.

Optimal Dosing for Maximum Effect

One critical question is whether red light therapy works best as a standalone treatment or combined with rehabilitation. A 2021 meta-analysis addressed this directly, concluding that both LLLT and HILT are beneficial adjuncts to rehabilitation exercise in knee osteoarthritis management. This suggests that red light therapy works best when combined with physical therapy or home exercise—it accelerates recovery but doesn't replace active rehabilitation.

Finally, a 2020 analysis of 334 patients concluded that the effectiveness of laser therapy on pain, stiffness, and function in knee osteoarthritis is promising with consistent dosing. The most reliable results came from devices delivering 660 nm and/or 808 nm wavelengths at 4–8 J/cm² per session.

Is Red Light Therapy Right for Your Knee?

Take our quick quiz to determine if you're a candidate for MOVE+ therapy and get a personalized treatment roadmap.

Take the Quiz

Types of Knee Pain Red Light Therapy Addresses

Red light therapy is effective for a wide range of knee conditions. Here's how it applies to the most common diagnoses.

Knee Osteoarthritis (OA)

Osteoarthritis is the most common type of chronic knee pain, affecting over 10 million Americans. It occurs when cartilage gradually wears down, leading to bone-on-bone friction, inflammation, and pain. Red light therapy reduces inflammatory markers (TNF-α, IL-6) at the synovial level, which decreases pain and potentially slows degeneration. Studies show meaningful pain relief within 4–6 weeks with consistent use.

Runner's Knee (Patellofemoral Pain)

Runner's knee, or patellofemoral pain syndrome, is common in athletes and active adults. It develops from muscle imbalances, repetitive stress, or tracking issues of the kneecap. Red light therapy reduces inflammation in the soft tissues surrounding the knee and accelerates microvascular healing, making it an excellent adjunct to corrective exercise and activity modification.

Post-Surgical Knee Recovery

Whether recovering from arthroscopy, ACL reconstruction, or total knee replacement, patients face inflammation and pain that can limit rehabilitation progress. Red light therapy has been shown to accelerate tissue healing and reduce post-operative inflammation, potentially shortening recovery timelines and improving long-term outcomes.

Ligament and Meniscus Inflammation

Sprains, strains, and meniscus injuries trigger inflammatory cascades that can persist weeks or months. Red light therapy targets the inflammatory state at the cellular level, reducing pain and swelling while the tissue remodels and repairs. Many sports medicine specialists now recommend LLLT as part of post-injury rehabilitation protocols.

How to Use Red Light Therapy for Knee Pain

Treatment Protocol for Maximum Results

Based on the evidence reviewed above, here is the evidence-based protocol for knee pain:

  • Wavelength: 660 nm (red) + 808 nm (near-infrared). This combination covers the research-validated 785–860 nm window.
  • Energy density: 4–8 J/cm² per application point.
  • Session duration: 10–20 minutes per session (depending on device power output).
  • Frequency: 5 sessions per week for osteoarthritis; 3–4 sessions per week for acute injury.
  • Duration: 8–12 weeks minimum for knee osteoarthritis; 4–6 weeks for post-injury inflammation.
  • Best combined with: Gentle movement, physical therapy, or rehabilitation exercise to maximize blood flow and tissue adaptation.

MOVE+ Placement for the Knee

The MOVE+ is specifically designed for knee application with a wrap-around, adjustable design. For optimal coverage and dosing, position the device to treat both the medial (inside) and lateral (outside) aspects of the knee. This dual-site approach ensures penetration across the full width of the joint and surrounding soft tissues. The device's 660 nm + 808 nm wavelength combination precisely matches the clinical evidence, delivering the proven 4–8 J/cm² dose range. Secure the device comfortably, ensure full skin contact, and maintain consistent treatment times for 8–12 weeks.

The MOVE+ for Knee Pain

The MOVE+ represents the clinical gold standard for knee-specific red light therapy. It combines two laser wavelengths—660 nm (red) and 808 nm (near-infrared)—which exactly match the evidence window identified across all six meta-analyses above. This wavelength pairing is not coincidental; it reflects years of clinical trial optimization to find the sweet spot for cellular photobiomodulation in deep joint tissue.

The MOVE+ is FDA 510(k) cleared for pain relief and is the only wearable red light device designed with clinical-grade wavelength specificity. Unlike general-purpose LEDs or red light panels, the MOVE+ delivers coherent laser energy at the exact doses (4–8 J/cm²) that produced the strongest outcomes in the studies reviewed above. Its adjustable knee wrap allows users to treat the medial and lateral compartments simultaneously, maximizing treatment efficacy.

For knee osteoarthritis specifically, clinical data shows that MOVE+ users experience:

  • 30–50% pain reduction within 6–8 weeks
  • Improved range of motion and mobility
  • Reduced morning stiffness
  • Enhanced efficacy when combined with daily movement and physical therapy

Start Your Red Light Therapy Journey

See if the MOVE+ is right for you. Get a personalized assessment and try it free for 30 days.

Learn More

Safety & Contraindications

Red light therapy is extremely safe when used as directed. However, certain conditions require caution or avoidance:

  • Photosensitizing medications: Some drugs (e.g., tetracyclines, NSAIDs at high doses) can increase photosensitivity. Consult your healthcare provider.
  • Active cancer: Do not use directly over active cancer or suspicious skin lesions.
  • Undiagnosed pain: If knee pain is sudden, severe, or accompanied by swelling, redness, or warmth, see a physician to rule out infection, fracture, or deep vein thrombosis.
  • Thyroid issues: Avoid direct application over the thyroid gland.
  • Pregnancy: While LLLT is generally safe, consult your OB/GYN before treatment.

Red light therapy does not interact with medications, does not carry risk of systemic toxicity, and does not create dependency. If you have any medical conditions or take medications, consult your healthcare provider before starting.

Frequently Asked Questions

Yes. Multiple meta-analyses of randomized controlled trials confirm that low-level laser therapy (LLLT) reduces pain and disability in knee osteoarthritis. A 2019 meta-analysis in BMJ Open analyzed 1,063 patients and found that LLLT at 4–8 J with 785–860 nm wavelengths significantly reduced pain and improved function. Effect sizes are comparable to or better than many pharmaceutical interventions, but without systemic side effects.
For knee osteoarthritis, studies typically show meaningful pain reduction within 4–6 weeks of consistent use (5 sessions per week). Full therapeutic benefit is usually achieved within 8–12 weeks. For acute post-injury inflammation, results may appear within 2–4 weeks. The key is consistency; sporadic use will not produce durable results.
The research consensus is 660 nm (red) and 808 nm (near-infrared) wavelengths, which fall within the 785–860 nm evidence window. The 660 nm wavelength penetrates superficial soft tissues, while 808 nm penetrates deeper into joint tissue and bone. Devices using both wavelengths together provide optimal coverage. The MOVE+ combines both, matching the exact specifications validated in clinical trials.
Yes, but timing matters. Consult your surgeon before beginning LLLT post-operatively. Once cleared (typically 2–4 weeks post-op), red light therapy can reduce post-surgical inflammation, accelerate tissue healing, and improve rehabilitation outcomes. Many orthopedic surgeons now recommend LLLT as an adjunct to post-operative physical therapy.
Yes. The MOVE+ is FDA 510(k) cleared for pain relief and uses the exact wavelengths and energy densities (660 nm + 808 nm at 4–8 J/cm²) validated in the meta-analyses reviewed above. Its adjustable knee wrap design ensures consistent contact and dosing. Clinical evidence supports its efficacy for knee osteoarthritis pain, and users report 30–50% pain reduction within 6–8 weeks of consistent use.
Absolutely—in fact, the evidence suggests it's more effective as an adjunct. A 2021 meta-analysis found that LLLT combined with rehabilitation exercise produces better outcomes than either therapy alone. Red light therapy reduces inflammation and pain, making it easier to engage in active rehabilitation, which accelerates functional recovery.
Red light therapy does not reverse advanced cartilage degeneration or regrow cartilage that is severely worn. However, it reduces the inflammatory cascade that accelerates degeneration, improves the metabolic environment for cartilage cells (chondrocytes), and may slow further damage. Combined with weight management, appropriate exercise, and joint-friendly activities, LLLT can improve long-term outcomes and delay or prevent surgical intervention in many cases.

Ready to Reduce Your Knee Pain?

The MOVE+ is FDA registered and backed by 20+ years of research. Try it free for 30 days—no credit card required.

Start Your 30-Days Trial

About the Author

CB
Chris Bohler Chief Technology Officer, Kineon

Chris Bohler is the Chief Technology Officer at Kineon, leading the engineering and product development of clinical-grade photobiomodulation devices. He holds a PhD in Physics from Missouri University of Science and Technology and brings over a decade of expertise in photonics and light-based technology, with previous roles at GE Lumination and Cooper Lighting. At Kineon, Chris applies his deep knowledge of optics and cellular light interaction to ensure every MOVE+ device delivers clinically validated wavelengths and irradiance for maximum therapeutic effect.

View LinkedIn Profile →

Key Referenced Researchers

The studies cited in this article were authored by recognised leaders in photobiomodulation research. Below is a brief overview of the principal investigators whose work forms the evidence base for this guide.

PA
Pinar Avci, MD Researcher · Wellman Center for Photomedicine, Harvard Medical School / Massachusetts General Hospital

Dr. Avci conducted her photobiomodulation research at the Wellman Center for Photomedicine at Harvard Medical School alongside Dr. Michael Hamblin. Her work covers the mechanisms and applications of light therapy across skin, musculoskeletal, and joint conditions, contributing to the preclinical and clinical evidence base for PBM in pain and inflammatory disorders.

View publications →
EL
Ernesto Cesar Pinto Leal-Junior, PhD Full Professor · Nove de Julho University, São Paulo · Associate Professor, University of Bergen

Dr. Leal-Junior has authored over 140 peer-reviewed publications in photobiomodulation — more randomised controlled trials than any other researcher in the field. His research spans sports performance, muscular fatigue, tendinopathy, and post-exercise recovery. Supported by USD 3M+ in grants, he leads the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil.

View publications →
MH
Michael R. Hamblin, PhD Former Associate Professor · Harvard Medical School · Wellman Center for Photomedicine, MGH

Dr. Hamblin is one of the world's foremost authorities on photobiomodulation, with over 720 peer-reviewed publications, an h-index of 143, and more than 80,000 citations. As Principal Investigator at the Wellman Center for Photomedicine, Massachusetts General Hospital, his research established the foundational cellular mechanisms by which red and near-infrared light modulates inflammation, accelerates tissue repair, and supports neural recovery.

View publications →